Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sirolimus for Autoimmune Disease of Blood Cells

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Children's Hospital of Philadelphia Identifier:
First received: October 24, 2006
Last updated: April 22, 2016
Last verified: April 2016